Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MURPHY WK")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

TRITIATED THYMIDINE LABELING INDEX AND RESPONSE IN HUMAN BREAST CANCERSULKES A; LIVINGSTON RB; MURPHY WK et al.1979; J. NATION. CANCER INST.; USA; DA. 1979; VOL. 62; NO 3; PP. 513-515; BIBL. 10 REF.Article

ADRIAMYCIN, BCNU, FTORAFUR CHEMOTHERAPY OF PANCREATIC AND BILIARY TRACT CANCERHALL SW; BENJAMIN RS; MURPHY WK et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 6; PP. 2008-2013; BIBL. 19 REF.Article

A RAPID IN VITRO LABELING INDEX METHOD FOR PREDICTING RESPONSE OF HUMAN SOLID TUMORS TO CHEMOTHERAPY.THIRLWELL MP; LIVINGSTON RB; MURPHY WK et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 9 PART. 1; PP. 3279-3283; BIBL. 17 REF.Article

INITIAL CLINICAL STUDIES WITH BRUCEANTINBEDIKIAN AY; VALDIVIESO M; BODEY GP et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1843-1847; BIBL. 3 REF.Article

LETHAL AND CYTOKINETIC EFFECTS OF ANGUIDINE ON A HUMAN COLON CANCER CELL LINEDOSIK GM; BARLOGIE B; JOHNSTON DA et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 10; PP. 3304-3309; BIBL. 40 REF.Article

PROTECTED ENVIRONMENT-PROPHYLACTIC ANTIBIOTIC PROGRAM FOR MALIGNANT SARCOMAS: RANDOMIZED TRIAL DURING REMISSION INDUCTION CHEMOTHERAPYBODEY GP; RODRIGUEZ V; MURPHY WK et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 10; PP. 2422-2429; BIBL. 21 REF.Article

PHASE II STUDY OF ANGUIDINE IN ADVANCED BREAST CANCERYAP HY; MURPHY WK; DISTEFANO A et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 789-791; BIBL. 6 REF.Article

NEOCARZINOSTATIN: A PHASE 1 CLINICAL TRIAL WITH FIVE-DAY INTERMITTENT AND CONTINUOUS INFUSIONSMCKELVEY EM; BURGESS MA; MCCREDIE KB et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 4; PP. 1182-1188; BIBL. 27 REF.Article

A PHASE I STUDY OF PYRAZOFURIN.SALEM PA; BODEY GP; BURGESS MA et al.1977; CANCER; U.S.A.; DA. 1977; VOL. 40; NO 6; PP. 2806-2809; BIBL. 6 REF.Article

A PHARMACOKINETICALLY BASED PHASE I-II STUDY OF SINGLE-DOSE ACTINOMYCIN D(NSC-3053)BENJAMIN RS; HALL SW; BURGESS MA et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 289-291; BIBL. 11 REF.Article

PHASE I CLINICAL EVALUATION OF 2,3-DIHYDRO-1H-IMIDAZO (1,2-B) PYRAZOLEBOH SENG YAP; MURPHY WK; BURGESS MA et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1849-1851; BIBL. 4 REF.Article

PHASE I CLINICAL EVALUATION OF ANGUIDINEMURPHY WK; BURGESS MA; VALDIVIESO M et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 10; PP. 1497-1502; BIBL. 9 REF.Article

PHASE II EVALUATION OF AMSA IN ADULT SARCOMASBOH SENG YAP; PLAGER C; BENJAMIN RS et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 341-343; BIBL. 6 REF.Article

CLINICAL PHASE I-II STUDY OF CIS-DICHLORO-DIAMMINE-PLATINUM(II) GIVEN BY CONTINUOUS I.V. INFUSIONSALEM P; HALL SW; BENJAMIN RS et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 10; PP. 1553-1555; BIBL. 9 REF.Article

A PHASE II EVALUATION OF METHYL CCNU AND ACTINOMYCIN D IN THE TREATMENT OF ADVANCED SARCOMAS IN ADULTSBOH SENG YAP; BENJAMIN RS; BURGESS MA et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 12; PP. 2807-2809; BIBL. 7 REF.Article

CHEMOIMMUNOTHERAPY OF DISSEMINATED MALIGNANT MELANOMA WITH DTIC-BCG, TRANSFER FACTOR+MELPHALANSCHWARZ MA; GUTTERMAN JU; BURGESS MA et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 10; PP. 2506-2515; BIBL. 46 REF.Article

PHASE 2 STUDY WITH BAKER'S ANTIFOL IN SOLID TUMORS.RODRIGUEZ V; RICHMAN SP; BENJAMIN RS et al.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 4; PP. 980-983; BIBL. 5 REF.Article

THE NATURAL HISTORY OF RESECTABLE METASTATIC MELANOMA (STAGE IV A MELANOMA)FEUN LG; GUTTERMAN J; BURGESS MA et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 8; PP. 1656-1663; BIBL. 23 REF.Article

  • Page / 1